Metabolic Resuscitation Using Hydrocortisone, Ascorbic Acid, and Thiamine: Do Individual Components Influence Reversal of Shock Independently?

被引:13
|
作者
Reddy, Paidi Ramakrishna [1 ]
Samavedam, Srinivas [1 ]
Aluru, Narmada [1 ]
Yelle, Sangeeta [1 ]
Rajyalakshmi, Boggu [1 ]
机构
[1] Virinchi Hosp, Dept Crit Care, Hyderabad, Telangana, India
关键词
Adenosine triphosphate; Hydrocortisone; Metabolic resuscitation; Septic shock; Thiamine; Vitamin C; CRITICALLY-ILL PATIENTS; VITAMIN-C; SEPTIC SHOCK; OXIDATIVE STRESS; DOUBLE-BLIND; SEPSIS; DEFICIENCY; TRIAL;
D O I
10.5005/jp-journals-10071-23515
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Aims and objective: To study the effects of various components of"metabolic resuscitation" on the shock reversal among patients with septic shock Introduction: Sepsis is characterized by dysregulated host response to infection. Mitochondrial dysfunction which occurs early in sepsis is associated with multiorgan dysfunction. Therapies such as adequate resuscitation, early administration of antibiotics, and aggressive monitoring reduced mortality substantially but it still remains high for those with septic shock. Combination of vitamin C, hydrocortisone, and thiamine improved outcome in a retrospective study, but how effective is this therapy in isolation compared to combination has to be known before implementation. Materials and methods: This study is single-center, prospective, randomized nonblinded trial done in septic shock patients admitted to the medical intensive care unit. Subjects were randomized to three groups of hydrocortisone (H), hydrocortisone, ascorbic acid (HA), hydrocortisone, ascorbic acid, thiamine (HAT). Following randomization, they received hydrocortisone 200 mg over 24 hours as infusion, intravenous ascorbic acid 1.5 g every 6 hours, thiamine 200 mg twice daily as allotted and continued till shock reversal or death. Primary outcome is time to shock reversal and secondary outcome is time to vasopressor dose reduction from hemodynamic SOFA score 4-3. Results: Twenty seven subjects were randomized into 3 groups of 9 each, of which 17 (63%) patients met primary outcome and secondary outcome has been studied in 16 (59%) patients. Eight patients (29.5%) died and did not meet either outcome and two patients (7.5%) met secondary outcome but not primary outcome because of discharge to other hospital. There is no difference in time to shock reversal [mean, SD in H (7422, 8348), HA (2528, 3086), HAT (1860, 749), p value 0.17]. There is no difference in time to shock reversal from hemodynamic SOFA 4-3 [mean, SD in H (4935, 6406), HA (2310, 2515), HAT (1800, 1282), p value 0.35]. Conclusion: In patients with septic shock, there is no difference in time to shock reversal comparing individual components of metabolic resuscitation.
引用
收藏
页码:649 / 652
页数:4
相关论文
共 22 条
  • [1] Corticosteroids and metabolic resuscitation (hydrocortisone, ascorbic acid and thiamine) in sepsis and septic shock
    Ramirez Montero, Victor
    Moragues Ribes, Concepcion
    Parejo Montell, Martin
    Zaragoza Crespo, Rafael
    MEDICINA INTENSIVA, 2022, 46 : 49 - 59
  • [2] Use of Hydrocortisone, Ascorbic Acid, and Thiamine in Adults with Septic Shock
    Vail, Emily A.
    Wunsch, Hannah
    Pinto, Ruxandra
    Bosch, Nicholas A.
    Walkey, Allan J.
    Lindenauer, Peter K.
    Gershengorn, Hayley B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (11) : 1531 - 1539
  • [3] THE BENEFIT OF INTRAVENOUS ASCORBIC ACID, HYDROCORTISONE, AND THIAMINE IN SEPSIS AND SEPTIC SHOCK
    Chung, Juri
    Wang, Shan
    Joseph, D'Andrea
    Akerman, Meredith
    Malone, Brian
    Hanna, Adel
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 639 - 639
  • [4] ASCORBIC ACID, THIAMINE, AND HYDROCORTISONE FOR IMPROVING ICU MORTALITY OUTCOMES IN SEPTIC SHOCK
    Greenley, Ryan
    Fryckberg, Anthony
    Kirkham, Jay
    Willsie, Philip
    Wiley, Joan
    Schiers, Kelly
    Malik, Neveen
    Michelle Nguyen
    CRITICAL CARE MEDICINE, 2019, 47
  • [5] HYDROCORTISONE/ASCORBIC ACID/THIAMINE USE ASSOCIATED WITH LOWER MORTALITY IN PEDIATRIC SEPTIC SHOCK
    Wald, Eric
    Sanchez-Pinto, L. Nelson
    Smith, Craig
    Moran, Thomas
    Badke, Colleen
    Barhight, Matthew
    Malakooti, Marcelo
    CRITICAL CARE MEDICINE, 2020, 48
  • [6] The Use of Hydrocortisone, Ascorbic Acid and Thiamine in Patients with Sepsis and Septic Shock - A Systematic Review
    Wang, Kunkun
    Yin, Ling
    Song, Yang
    Zhang, Mengqi
    Lu, Yun
    Wang, Shan
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (04) : 933 - 940
  • [7] Unanswered questions on the use of hydrocortisone, ascorbic acid, and thiamine therapy in sepsis and septic shock
    Ragoonanan, David
    Tran, Nicolas
    Modi, Veeshal
    Morgan Nickelsen, Paige
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (19) : 1626 - 1633
  • [8] Thiamine, Ascorbic Acid, and Hydrocortisone As a Metabolic Resuscitation Cocktail in Sepsis: A Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis*
    Assouline, Benjamin
    Faivre, Anna
    Verissimo, Thomas
    Sangla, Frederic
    Berchtold, Lena
    Giraud, Raphael
    Bendjelid, Karim
    Sgardello, Sebastian
    Elia, Nadia
    Pugin, Jerome
    de Seigneux, Sophie
    Legouis, David
    CRITICAL CARE MEDICINE, 2021, 49 (12) : 2112 - 2120
  • [9] Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis The ORANGES Trial
    Iglesias, Jose
    Vassallo, Andrew V.
    Patel, Vishal V.
    Sullivan, Jesse B.
    Cavanaugh, Joseph
    Elbaga, Yasmine
    CHEST, 2020, 158 (01) : 164 - 173
  • [10] Benefits of combination therapy of hydrocortisone, ascorbic acid and thiamine in sepsis and septic shock: A systematic review
    Lee, Young Ran
    Vo, Kandace
    Varughese, Jincy Thazhampallatu
    NUTRITION AND HEALTH, 2022, 28 (01) : 77 - 93